8 completed, 3 terminated. 7 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 4, Terminated 3 |
| Phase 2 | 4 | Completed 4 |
Follow satavaptan: new trials by email Literature Review of satavaptan trials Research Report on satavaptan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia Satavaptan, placebo - Hyponatremia, Inappropriate ADH Syndrome | Phase 3 | Terminated | Sanofi | 2 | 2008-07-01 | 2016-05-26 |
| Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver Satavaptan, placebo - Ascites, Liver Cirrhosis | Phase 3 | Terminated | Sanofi | 241 | 2006-08-01 | 2016-05-18 |
| Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS) Satavaptan, placebo - Ascites, Liver Cirrhosis | Phase 3 | Completed | Sanofi | 463 | 2006-07-01 | 2016-05-26 |
| Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver Satavaptan, placebo - Ascites, Liver Cirrhosis | Phase 3 | Terminated | Sanofi | 501 | 2006-07-01 | 2016-05-24 |
| Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion SR121463B - Inappropriate ADH Syndrome, Hyponatremia | Phase 3 | Completed | Sanofi | 57 | 2005-07-01 | 2009-01-21 |
| DILIPO (DILutIonal HyPOnatremia) SR121463B - Congestive Heart Failure | Phase 3 | Completed | Sanofi | 150 | 2005-05-01 | 2008-09-15 |
| Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion SR121463B - Inappropriate ADH Syndrome, Hyponatremia | Phase 3 | Completed | Sanofi | 77 | 2004-05-01 | 2008-12-10 |
| Satavaptan Dose-Ranging Study in the Prevention of Ascites satavaptan (SR121463B) - Ascites, Liver Cirrhosis | Phase 2 | Completed | Sanofi | 151 | 2004-04-01 | 2009-01-12 |
| Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites satavaptan (SR121463B) - Ascites, Liver Cirrhosis | Phase 2 | Completed | Sanofi | 110 | 2004-04-01 | 2009-01-12 |
| Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites satavaptan (SR121463B) - Ascites, Liver Cirrhosis | Phase 2 | Completed | Sanofi | 148 | 2004-04-01 | 2007-07-16 |
| Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion satavaptan (SR121463B) - Syndrome of Inappropriate ADH (SIADH) Secretion, Hyponatremia | Phase 2 | Completed | Sanofi | 35 | 2001-06-01 | 2008-06-17 |
Ascites (6) · Hyponatremia (6) · Liver Cirrhosis (6) · Inappropriate ADH Syndrome (4) · Heart Failure (1)
Sanofi (11)
Belgium (10) · Canada (9) · Australia (8) · France (8) · Germany (8) · Hungary (8) · United States (8) · Argentina (7) · Spain (7) · Croatia (6) · Romania (6) · Czechia (5) · Italy (5) · Brazil (4) · Portugal (4)